Rank | Gene Set | Z-score |
---|---|---|
1 | epoxygenase P450 pathway (GO:0019373) | 9.02826427 |
2 | exogenous drug catabolic process (GO:0042738) | 8.71708772 |
3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.36580663 |
4 | drug catabolic process (GO:0042737) | 8.21618353 |
5 | complement activation, alternative pathway (GO:0006957) | 7.50567842 |
6 | regulation of fibrinolysis (GO:0051917) | 7.47636828 |
7 | glyoxylate metabolic process (GO:0046487) | 7.43325150 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.34179694 |
9 | L-phenylalanine catabolic process (GO:0006559) | 7.34179694 |
10 | regulation of protein activation cascade (GO:2000257) | 7.27511601 |
11 | negative regulation of fibrinolysis (GO:0051918) | 7.24911871 |
12 | ethanol oxidation (GO:0006069) | 7.12898032 |
13 | regulation of complement activation (GO:0030449) | 6.86949796 |
14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.81432164 |
15 | L-phenylalanine metabolic process (GO:0006558) | 6.81432164 |
16 | urea metabolic process (GO:0019627) | 6.47357564 |
17 | drug metabolic process (GO:0017144) | 6.38852633 |
18 | * cellular glucuronidation (GO:0052695) | 6.10553235 |
19 | nitrogen cycle metabolic process (GO:0071941) | 5.89756758 |
20 | fibrinolysis (GO:0042730) | 5.84735422 |
21 | protein carboxylation (GO:0018214) | 5.82817784 |
22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.82817784 |
23 | * glucuronate metabolic process (GO:0019585) | 5.81532308 |
24 | * uronic acid metabolic process (GO:0006063) | 5.81532308 |
25 | ethanol metabolic process (GO:0006067) | 5.74977003 |
26 | blood coagulation, intrinsic pathway (GO:0007597) | 5.59344320 |
27 | urea cycle (GO:0000050) | 5.56746814 |
28 | bile acid biosynthetic process (GO:0006699) | 5.53328879 |
29 | negative regulation of cholesterol transport (GO:0032375) | 5.48567559 |
30 | negative regulation of sterol transport (GO:0032372) | 5.48567559 |
31 | oxidative demethylation (GO:0070989) | 5.44984213 |
32 | aromatic amino acid family catabolic process (GO:0009074) | 5.41842606 |
33 | bile acid metabolic process (GO:0008206) | 5.38966471 |
34 | regulation of triglyceride catabolic process (GO:0010896) | 5.35285386 |
35 | serine family amino acid catabolic process (GO:0009071) | 5.14666738 |
36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.06839263 |
37 | bile acid and bile salt transport (GO:0015721) | 5.04854302 |
38 | phenylpropanoid metabolic process (GO:0009698) | 4.92255050 |
39 | protein activation cascade (GO:0072376) | 4.84039900 |
40 | regulation of plasminogen activation (GO:0010755) | 4.73143802 |
41 | glycine metabolic process (GO:0006544) | 4.62627505 |
42 | negative regulation of blood coagulation (GO:0030195) | 4.59500056 |
43 | negative regulation of hemostasis (GO:1900047) | 4.59500056 |
44 | complement activation (GO:0006956) | 4.56886172 |
45 | complement activation, classical pathway (GO:0006958) | 4.55921580 |
46 | imidazole-containing compound metabolic process (GO:0052803) | 4.51464226 |
47 | S-adenosylmethionine metabolic process (GO:0046500) | 4.43589749 |
48 | negative regulation of protein activation cascade (GO:2000258) | 4.42869154 |
49 | flavonoid metabolic process (GO:0009812) | 4.35271648 |
50 | phospholipid efflux (GO:0033700) | 4.33787796 |
51 | hormone catabolic process (GO:0042447) | 4.33519948 |
52 | triglyceride homeostasis (GO:0070328) | 4.32504671 |
53 | acylglycerol homeostasis (GO:0055090) | 4.32504671 |
54 | regulation of humoral immune response (GO:0002920) | 4.31344699 |
55 | acute-phase response (GO:0006953) | 4.31190254 |
56 | tyrosine metabolic process (GO:0006570) | 4.30576328 |
57 | cholesterol efflux (GO:0033344) | 4.29455189 |
58 | amino-acid betaine metabolic process (GO:0006577) | 4.28600938 |
59 | protein-lipid complex remodeling (GO:0034368) | 4.27556440 |
60 | macromolecular complex remodeling (GO:0034367) | 4.27556440 |
61 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27556440 |
62 | high-density lipoprotein particle remodeling (GO:0034375) | 4.24907459 |
63 | negative regulation of coagulation (GO:0050819) | 4.22714028 |
64 | response to mercury ion (GO:0046689) | 4.15076888 |
65 | negative regulation of wound healing (GO:0061045) | 4.15065429 |
66 | alkaloid metabolic process (GO:0009820) | 4.14398079 |
67 | regulation of cholesterol esterification (GO:0010872) | 4.13303933 |
68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.13129942 |
69 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.13129942 |
70 | intestinal cholesterol absorption (GO:0030299) | 4.11436067 |
71 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.04313676 |
72 | glutamate metabolic process (GO:0006536) | 4.02708127 |
73 | arginine metabolic process (GO:0006525) | 3.96919594 |
74 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.87296273 |
75 | opsonization (GO:0008228) | 3.87125552 |
76 | cytolysis (GO:0019835) | 3.85030327 |
77 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84983349 |
78 | reverse cholesterol transport (GO:0043691) | 3.84736090 |
79 | negative regulation of lipase activity (GO:0060192) | 3.80064726 |
80 | serine family amino acid metabolic process (GO:0009069) | 3.76903007 |
81 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.75986246 |
82 | alpha-amino acid catabolic process (GO:1901606) | 3.74917377 |
83 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.73631490 |
84 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.73631490 |
85 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73340902 |
86 | positive regulation of hemostasis (GO:1900048) | 3.71320952 |
87 | positive regulation of blood coagulation (GO:0030194) | 3.71320952 |
88 | tryptophan catabolic process (GO:0006569) | 3.70876305 |
89 | indole-containing compound catabolic process (GO:0042436) | 3.70876305 |
90 | indolalkylamine catabolic process (GO:0046218) | 3.70876305 |
91 | heme transport (GO:0015886) | 3.69917219 |
92 | negative regulation of complement activation (GO:0045916) | 3.66486489 |
93 | xenobiotic metabolic process (GO:0006805) | 3.64384606 |
94 | aromatic amino acid family metabolic process (GO:0009072) | 3.56519355 |
95 | drug transmembrane transport (GO:0006855) | 3.56050919 |
96 | positive regulation of lipid catabolic process (GO:0050996) | 3.46010027 |
97 | sodium-independent organic anion transport (GO:0043252) | 3.44358297 |
98 | positive regulation of coagulation (GO:0050820) | 3.42852549 |
99 | xenobiotic catabolic process (GO:0042178) | 3.40271505 |
100 | primary alcohol catabolic process (GO:0034310) | 3.39810353 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.60257027 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.55723164 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.47802188 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.46201357 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.73917995 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.13258195 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.92477782 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.63225516 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.60270781 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.86539363 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.47496077 |
12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.22290050 |
13 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.21851956 |
14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03545848 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.6451498 |
16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87220012 |
17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.59660578 |
18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56473799 |
19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43976184 |
20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40673791 |
21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36328558 |
22 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35953351 |
23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31267985 |
24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28242720 |
25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22767633 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21455515 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20893099 |
28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20679291 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16007153 |
30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14073221 |
31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06465795 |
32 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05326392 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02768312 |
34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02253662 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00677080 |
36 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98434230 |
37 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98313153 |
38 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97841344 |
39 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.92027280 |
40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91849547 |
41 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.91824921 |
42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91137144 |
43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90867763 |
44 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90454933 |
45 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89833025 |
46 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88138864 |
47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86194201 |
48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86140420 |
49 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85867061 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85653384 |
51 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84993111 |
52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84630704 |
53 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.84155768 |
54 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82848912 |
55 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.81145383 |
56 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80034092 |
57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79448821 |
58 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78703767 |
59 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78562030 |
60 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.78375515 |
61 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77747122 |
62 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76740203 |
63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74375833 |
64 | NFYA_21822215_ChIP-Seq_K562_Human | 0.72844027 |
65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.71846205 |
66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71801993 |
67 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.70560632 |
68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.67571180 |
69 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.66096062 |
70 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65415684 |
71 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.65367293 |
72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63866022 |
73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.63719977 |
74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.61597710 |
75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.60615044 |
76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.59987659 |
77 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.59368785 |
78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.59143694 |
79 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57878184 |
80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57827893 |
81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.57612787 |
82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.57612787 |
83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.57186826 |
84 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55971766 |
85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.55866825 |
86 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.55274939 |
87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.54676397 |
88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.54661354 |
89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.54658941 |
90 | NFYB_21822215_ChIP-Seq_K562_Human | 0.54179287 |
91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.54137802 |
92 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.53812600 |
93 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.53731506 |
94 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52650651 |
95 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.52522746 |
96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52423261 |
97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.51781411 |
98 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.51130687 |
99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51060560 |
100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.50467645 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 9.22337007 |
2 | MP0005360_urolithiasis | 7.07603303 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.30218961 |
4 | MP0005365_abnormal_bile_salt | 5.64740843 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.39343815 |
6 | MP0003195_calcinosis | 4.96097558 |
7 | MP0003252_abnormal_bile_duct | 4.15782334 |
8 | MP0002138_abnormal_hepatobiliary_system | 4.04465285 |
9 | MP0001666_abnormal_nutrient_absorption | 3.79087944 |
10 | MP0003868_abnormal_feces_composition | 3.25891982 |
11 | MP0010329_abnormal_lipoprotein_level | 2.91441076 |
12 | MP0005332_abnormal_amino_acid | 2.58597499 |
13 | MP0009697_abnormal_copulation | 2.55029093 |
14 | MP0003806_abnormal_nucleotide_metabolis | 2.42772315 |
15 | MP0009840_abnormal_foam_cell | 2.31856874 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.06996668 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.03658073 |
18 | MP0002876_abnormal_thyroid_physiology | 2.00318276 |
19 | MP0000609_abnormal_liver_physiology | 1.78405106 |
20 | MP0002118_abnormal_lipid_homeostasis | 1.70890095 |
21 | MP0001764_abnormal_homeostasis | 1.65354523 |
22 | MP0010368_abnormal_lymphatic_system | 1.47361018 |
23 | MP0009643_abnormal_urine_homeostasis | 1.38728758 |
24 | MP0005670_abnormal_white_adipose | 1.34952993 |
25 | MP0005408_hypopigmentation | 1.25897716 |
26 | MP0002132_abnormal_respiratory_system | 1.20966026 |
27 | MP0005319_abnormal_enzyme/_coenzyme | 1.11826958 |
28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07470891 |
29 | MP0005636_abnormal_mineral_homeostasis | 1.06193442 |
30 | MP0000598_abnormal_liver_morphology | 1.00339404 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 0.97856599 |
32 | MP0003879_abnormal_hair_cell | 0.96942604 |
33 | MP0003183_abnormal_peptide_metabolism | 0.92680691 |
34 | MP0001661_extended_life_span | 0.92634476 |
35 | MP0005451_abnormal_body_composition | 0.92471580 |
36 | MP0009642_abnormal_blood_homeostasis | 0.89349606 |
37 | MP0008872_abnormal_physiological_respon | 0.86101830 |
38 | MP0008469_abnormal_protein_level | 0.79686090 |
39 | MP0005376_homeostasis/metabolism_phenot | 0.78310519 |
40 | MP0009763_increased_sensitivity_to | 0.77759091 |
41 | MP0002971_abnormal_brown_adipose | 0.76635931 |
42 | MP0000604_amyloidosis | 0.75859234 |
43 | MP0009053_abnormal_anal_canal | 0.73888638 |
44 | MP0003186_abnormal_redox_activity | 0.73760884 |
45 | MP0004043_abnormal_pH_regulation | 0.73682386 |
46 | MP0009764_decreased_sensitivity_to | 0.73541766 |
47 | MP0005395_other_phenotype | 0.72414591 |
48 | MP0001756_abnormal_urination | 0.72034071 |
49 | MP0005535_abnormal_body_temperature | 0.69608463 |
50 | MP0002136_abnormal_kidney_physiology | 0.66533626 |
51 | MP0001915_intracranial_hemorrhage | 0.64269324 |
52 | MP0003638_abnormal_response/metabolism_ | 0.60829579 |
53 | MP0002078_abnormal_glucose_homeostasis | 0.59868185 |
54 | MP0005187_abnormal_penis_morphology | 0.59851248 |
55 | MP0005464_abnormal_platelet_physiology | 0.57359791 |
56 | MP0002168_other_aberrant_phenotype | 0.56398622 |
57 | MP0009785_altered_susceptibility_to | 0.55377599 |
58 | MP0002282_abnormal_trachea_morphology | 0.54746192 |
59 | MP0005058_abnormal_lysosome_morphology | 0.52987743 |
60 | MP0005266_abnormal_metabolism | 0.52338070 |
61 | MP0005334_abnormal_fat_pad | 0.52277460 |
62 | MP0003011_delayed_dark_adaptation | 0.51888894 |
63 | MP0005166_decreased_susceptibility_to | 0.48931652 |
64 | MP0003718_maternal_effect | 0.46990461 |
65 | MP0005023_abnormal_wound_healing | 0.46483907 |
66 | MP0004272_abnormal_basement_membrane | 0.46130164 |
67 | MP0008874_decreased_physiological_sensi | 0.45828003 |
68 | MP0002249_abnormal_larynx_morphology | 0.45793242 |
69 | MP0003690_abnormal_glial_cell | 0.45315437 |
70 | MP0004264_abnormal_extraembryonic_tissu | 0.45084938 |
71 | MP0005448_abnormal_energy_balance | 0.44783599 |
72 | MP0000249_abnormal_blood_vessel | 0.43082831 |
73 | MP0004782_abnormal_surfactant_physiolog | 0.39561604 |
74 | MP0006036_abnormal_mitochondrial_physio | 0.39532125 |
75 | MP0005084_abnormal_gallbladder_morpholo | 0.39175374 |
76 | MP0003953_abnormal_hormone_level | 0.37978512 |
77 | MP0010386_abnormal_urinary_bladder | 0.35732595 |
78 | MP0009765_abnormal_xenobiotic_induced | 0.35224141 |
79 | MP0009115_abnormal_fat_cell | 0.34592878 |
80 | MP0000566_synostosis | 0.33707004 |
81 | MP0005164_abnormal_response_to | 0.32823650 |
82 | MP0004883_abnormal_blood_vessel | 0.31495186 |
83 | MP0005220_abnormal_exocrine_pancreas | 0.30718066 |
84 | MP0010155_abnormal_intestine_physiology | 0.30368798 |
85 | MP0002089_abnormal_postnatal_growth/wei | 0.27945386 |
86 | MP0002135_abnormal_kidney_morphology | 0.27907356 |
87 | MP0001845_abnormal_inflammatory_respons | 0.27489726 |
88 | MP0005409_darkened_coat_color | 0.25790430 |
89 | MP0004130_abnormal_muscle_cell | 0.23966867 |
90 | MP0001765_abnormal_ion_homeostasis | 0.22266657 |
91 | MP0003959_abnormal_lean_body | 0.21903049 |
92 | MP0002928_abnormal_bile_duct | 0.21865911 |
93 | MP0001881_abnormal_mammary_gland | 0.21690494 |
94 | MP0000467_abnormal_esophagus_morphology | 0.20484139 |
95 | MP0004147_increased_porphyrin_level | 0.20077663 |
96 | MP0003075_altered_response_to | 0.19966242 |
97 | MP0005647_abnormal_sex_gland | 0.18968578 |
98 | MP0000538_abnormal_urinary_bladder | 0.18377822 |
99 | MP0005666_abnormal_adipose_tissue | 0.17734052 |
100 | MP0000639_abnormal_adrenal_gland | 0.17152675 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.37256180 |
2 | Deep venous thrombosis (HP:0002625) | 9.11333810 |
3 | Complement deficiency (HP:0004431) | 8.96357113 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 8.17877603 |
5 | Hypobetalipoproteinemia (HP:0003563) | 8.01668032 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.66272423 |
7 | Abnormality of complement system (HP:0005339) | 7.20109899 |
8 | Conjugated hyperbilirubinemia (HP:0002908) | 6.44107272 |
9 | Systemic lupus erythematosus (HP:0002725) | 5.97710915 |
10 | Joint hemorrhage (HP:0005261) | 5.58255173 |
11 | Glomerulonephritis (HP:0000099) | 5.18982289 |
12 | Intrahepatic cholestasis (HP:0001406) | 5.07548837 |
13 | Hyperlipoproteinemia (HP:0010980) | 5.04478028 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.82530113 |
15 | Xanthomatosis (HP:0000991) | 4.81412111 |
16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.67832167 |
17 | Hypolipoproteinemia (HP:0010981) | 4.60346787 |
18 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.28741538 |
19 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.16473965 |
20 | Spontaneous abortion (HP:0005268) | 4.10441125 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.94330664 |
22 | Fat malabsorption (HP:0002630) | 3.92027968 |
23 | Nephritis (HP:0000123) | 3.76758459 |
24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.69886174 |
25 | Generalized aminoaciduria (HP:0002909) | 3.36696670 |
26 | Hyperammonemia (HP:0001987) | 3.27514305 |
27 | Hyperglycinemia (HP:0002154) | 3.24509818 |
28 | Abnormality of methionine metabolism (HP:0010901) | 3.13746432 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.13506682 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.13506682 |
31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.99359729 |
32 | Hypercholesterolemia (HP:0003124) | 2.97292008 |
33 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94629057 |
34 | Steatorrhea (HP:0002570) | 2.93991264 |
35 | Rickets (HP:0002748) | 2.91046774 |
36 | Osteomalacia (HP:0002749) | 2.90291471 |
37 | Hypoalphalipoproteinemia (HP:0003233) | 2.89132579 |
38 | Epidermoid cyst (HP:0200040) | 2.88836491 |
39 | Delayed CNS myelination (HP:0002188) | 2.88538539 |
40 | Vascular calcification (HP:0004934) | 2.88128674 |
41 | Gingival bleeding (HP:0000225) | 2.84896792 |
42 | Hyperglycinuria (HP:0003108) | 2.83989197 |
43 | Hyperbilirubinemia (HP:0002904) | 2.65928604 |
44 | Glycosuria (HP:0003076) | 2.63266607 |
45 | Abnormality of urine glucose concentration (HP:0011016) | 2.63266607 |
46 | Hyperphosphaturia (HP:0003109) | 2.60888495 |
47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59673063 |
48 | Hemorrhage of the eye (HP:0011885) | 2.58737074 |
49 | Abnormality of proline metabolism (HP:0010907) | 2.55504851 |
50 | Hydroxyprolinuria (HP:0003080) | 2.55504851 |
51 | Mitral stenosis (HP:0001718) | 2.53714378 |
52 | Cardiovascular calcification (HP:0011915) | 2.52968652 |
53 | Abnormality of serum amino acid levels (HP:0003112) | 2.52798763 |
54 | Abnormality of vitamin metabolism (HP:0100508) | 2.47377120 |
55 | Thrombophlebitis (HP:0004418) | 2.44324788 |
56 | Hepatocellular carcinoma (HP:0001402) | 2.42127927 |
57 | Alkalosis (HP:0001948) | 2.38442600 |
58 | Gout (HP:0001997) | 2.34546135 |
59 | Purpura (HP:0000979) | 2.34198198 |
60 | Fair hair (HP:0002286) | 2.34195275 |
61 | Abnormality of purine metabolism (HP:0004352) | 2.33160837 |
62 | Reduced antithrombin III activity (HP:0001976) | 2.25733946 |
63 | Metabolic acidosis (HP:0001942) | 2.23165863 |
64 | Abnormal urine phosphate concentration (HP:0012599) | 2.22952108 |
65 | Neonatal hypoglycemia (HP:0001998) | 2.19144906 |
66 | Menorrhagia (HP:0000132) | 2.18830445 |
67 | Proximal tubulopathy (HP:0000114) | 2.14443348 |
68 | Pulmonary embolism (HP:0002204) | 2.11999443 |
69 | Hypophosphatemic rickets (HP:0004912) | 2.11586669 |
70 | Acanthocytosis (HP:0001927) | 2.09877120 |
71 | Facial shape deformation (HP:0011334) | 2.06920389 |
72 | Potter facies (HP:0002009) | 2.06920389 |
73 | Elevated alkaline phosphatase (HP:0003155) | 2.04990617 |
74 | Poikilocytosis (HP:0004447) | 2.03133725 |
75 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.02641559 |
76 | Ketosis (HP:0001946) | 1.98745336 |
77 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97558035 |
78 | Irritability (HP:0000737) | 1.93129304 |
79 | Joint swelling (HP:0001386) | 1.92385033 |
80 | Enlarged kidneys (HP:0000105) | 1.82422401 |
81 | Hypophosphatemia (HP:0002148) | 1.81467774 |
82 | Abnormality of iron homeostasis (HP:0011031) | 1.78630775 |
83 | Cholelithiasis (HP:0001081) | 1.77842880 |
84 | Arthropathy (HP:0003040) | 1.77488911 |
85 | Abnormal platelet function (HP:0011869) | 1.76485787 |
86 | Impaired platelet aggregation (HP:0003540) | 1.76485787 |
87 | Nephrolithiasis (HP:0000787) | 1.75865630 |
88 | Myocardial infarction (HP:0001658) | 1.75159241 |
89 | Abnormal gallbladder physiology (HP:0012438) | 1.74986212 |
90 | Cholecystitis (HP:0001082) | 1.74986212 |
91 | Cerebral palsy (HP:0100021) | 1.74530884 |
92 | Increased serum ferritin (HP:0003281) | 1.71241135 |
93 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70996002 |
94 | Abnormal gallbladder morphology (HP:0012437) | 1.68347646 |
95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.67696023 |
96 | Abnormality of the Achilles tendon (HP:0005109) | 1.67566286 |
97 | Increased purine levels (HP:0004368) | 1.66415655 |
98 | Hyperuricemia (HP:0002149) | 1.66415655 |
99 | Skin nodule (HP:0200036) | 1.66261515 |
100 | Increased mean platelet volume (HP:0011877) | 1.65934213 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.31079333 |
2 | FGFR4 | 3.88699471 |
3 | WNK3 | 3.77237327 |
4 | ACVR1B | 3.37871435 |
5 | RIPK1 | 2.92771802 |
6 | OXSR1 | 2.89781640 |
7 | PIK3CA | 2.76450531 |
8 | MST1R | 2.63752151 |
9 | PIK3CG | 2.32128492 |
10 | PDK2 | 2.30735494 |
11 | FGFR3 | 2.20066049 |
12 | TYK2 | 1.93549656 |
13 | MYLK | 1.91532447 |
14 | PRKACG | 1.83259347 |
15 | PINK1 | 1.81693294 |
16 | MAP3K12 | 1.65079141 |
17 | STK39 | 1.63675065 |
18 | MAP3K3 | 1.63235819 |
19 | PRKAA2 | 1.62841896 |
20 | EPHA3 | 1.62781374 |
21 | MAP3K2 | 1.56510986 |
22 | MAPK11 | 1.55698226 |
23 | EPHA2 | 1.43760122 |
24 | WNK4 | 1.42095329 |
25 | SGK494 | 1.35104255 |
26 | SGK223 | 1.35104255 |
27 | BCKDK | 1.34537267 |
28 | SIK1 | 1.31688503 |
29 | NLK | 1.29737278 |
30 | PDPK1 | 1.29012372 |
31 | LATS1 | 1.25583651 |
32 | SGK2 | 1.25322552 |
33 | AKT3 | 1.24248392 |
34 | ABL2 | 1.24120640 |
35 | CASK | 1.23425210 |
36 | ERBB2 | 1.14320421 |
37 | IGF1R | 1.07395914 |
38 | MAP3K1 | 1.05335735 |
39 | TRIB3 | 1.04050994 |
40 | PRKG2 | 1.01809235 |
41 | SGK3 | 1.01655017 |
42 | GRK1 | 0.98343374 |
43 | MET | 0.96889595 |
44 | NEK9 | 0.95718035 |
45 | TGFBR2 | 0.95326089 |
46 | EPHA4 | 0.93177291 |
47 | BCR | 0.92959804 |
48 | TAOK3 | 0.92286645 |
49 | FER | 0.91907740 |
50 | JAK1 | 0.90966913 |
51 | PRKCZ | 0.89236143 |
52 | RET | 0.88651377 |
53 | PDK1 | 0.86586353 |
54 | MAP2K4 | 0.83193275 |
55 | FRK | 0.80303211 |
56 | ICK | 0.79533419 |
57 | PRKG1 | 0.79095151 |
58 | PRKAA1 | 0.78270205 |
59 | TBK1 | 0.76243724 |
60 | STK38 | 0.75520151 |
61 | STK38L | 0.75176013 |
62 | PRKCG | 0.72241256 |
63 | FGFR2 | 0.72141027 |
64 | PRKACA | 0.71390026 |
65 | MAPKAPK3 | 0.67227540 |
66 | JAK2 | 0.65798056 |
67 | CSF1R | 0.64229253 |
68 | NTRK3 | 0.63537213 |
69 | LMTK2 | 0.61121688 |
70 | PRKCA | 0.60434364 |
71 | EPHB1 | 0.59788056 |
72 | SGK1 | 0.59463730 |
73 | TIE1 | 0.54076069 |
74 | EIF2AK1 | 0.52311626 |
75 | INSRR | 0.52251647 |
76 | MELK | 0.50584125 |
77 | PDGFRA | 0.49743490 |
78 | PTK6 | 0.48469850 |
79 | MAP3K5 | 0.48329976 |
80 | TESK2 | 0.47332487 |
81 | PKN2 | 0.46074070 |
82 | PRKCB | 0.45245630 |
83 | CSNK1A1 | 0.44526425 |
84 | PRPF4B | 0.41787214 |
85 | PRKCQ | 0.39225722 |
86 | CSNK1E | 0.37099837 |
87 | GSK3A | 0.37091848 |
88 | MAP2K6 | 0.37044267 |
89 | MAP3K7 | 0.36444330 |
90 | PRKACB | 0.33116484 |
91 | RPS6KA3 | 0.32631796 |
92 | DYRK1B | 0.32115670 |
93 | IRAK3 | 0.31843448 |
94 | MAP3K11 | 0.30627411 |
95 | PRKCE | 0.29950905 |
96 | CSNK2A1 | 0.29316734 |
97 | MST4 | 0.29238377 |
98 | * SRC | 0.29228737 |
99 | BRSK2 | 0.28106777 |
100 | RPS6KB1 | 0.27800124 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.43173565 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.75105848 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.66624288 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.62398554 |
5 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.48772513 |
6 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.45411633 |
7 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.36263478 |
8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.91997695 |
9 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.88282694 |
10 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.73495086 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.58480511 |
12 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.57802807 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55660751 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54686358 |
15 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.48600727 |
16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.44764315 |
17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.31364739 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.15340022 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.01119851 |
20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.94472909 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88549723 |
22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87928350 |
23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83360137 |
24 | Bile secretion_Homo sapiens_hsa04976 | 1.80842678 |
25 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.75403673 |
26 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.74218443 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49057145 |
28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46004324 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32253638 |
30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31089212 |
31 | Peroxisome_Homo sapiens_hsa04146 | 1.26646955 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20908537 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19557998 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19083870 |
35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14763152 |
36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13821369 |
37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12855397 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11464816 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06481249 |
40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04707074 |
41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01381371 |
42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01274632 |
43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99061836 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98827221 |
45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96893546 |
46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95974722 |
47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.95834709 |
48 | Prion diseases_Homo sapiens_hsa05020 | 0.95114977 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82806786 |
50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79604739 |
51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79470375 |
52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78611559 |
53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78083601 |
54 | ABC transporters_Homo sapiens_hsa02010 | 0.75400787 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64402940 |
56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62148070 |
57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56308474 |
58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50461238 |
59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44465895 |
60 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43994383 |
61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41615900 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40761603 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 0.39552218 |
64 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36007723 |
65 | Mineral absorption_Homo sapiens_hsa04978 | 0.29639435 |
66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29559796 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26980619 |
68 | Pertussis_Homo sapiens_hsa05133 | 0.26819604 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 0.23410404 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22646985 |
71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.22511658 |
72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19041848 |
73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15693202 |
74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15281890 |
75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12354992 |
76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11516355 |
77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.10559237 |
78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.08764131 |
79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07816751 |
80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06227917 |
81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05525059 |
82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05133039 |
83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.05128737 |
84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.00409596 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.00231386 |
86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2540033 |
87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2123106 |
88 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1809250 |
89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1699591 |
90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1643812 |
91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1642647 |
92 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1491911 |
93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1094327 |
94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0905403 |
95 | Amoebiasis_Homo sapiens_hsa05146 | -0.0780851 |
96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0640047 |
97 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0535493 |
98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0475714 |
99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0277262 |
100 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0082428 |